Corticosteroids: quick reference for dose equivalents and stress dosing

Quick reference for the doctor on call and on the ward: equivalent doses, stress dosing in adrenal insufficiency, tapering, and prophylaxis against adverse effects.

Contents (6)

Two situations are often confused: replacement therapy in adrenal insufficiency (which must be increased under stress) and pharmacological anti-inflammatory treatment (which must be tapered in a controlled fashion). The management is the opposite in each case.

Equivalent doses

Agent Equivalent glucocorticoid dose Mineralocorticoid effect Biological half-life
Hydrocortisone (cortisol) 20 mg Marked Short, 8–12 hours
Prednisolone 5 mg Moderate Intermediate, 12–36 hours
Methylprednisolone 4 mg Low Intermediate
Betamethasone 0.6 mg None Long, 36–54 hours
Dexamethasone 0.75 mg None Long, 36–54 hours

The equivalences apply to the anti-inflammatory effect. They say nothing about the mineralocorticoid effect or about suppression of the HPA axis, where a long half-life produces more marked suppression.

Stress dosing in known adrenal insufficiency

A patient with primary adrenal insufficiency (Addison's disease), secondary adrenal insufficiency or long-term corticosteroid treatment cannot increase their own cortisol production.

Situation Action
Fever, infection or gastroenteritis at home Double or triple the oral daily dose during the days of illness (the patient's sick-day rules)
Vomiting or diarrhoea, unable to keep tablets down Parenteral hydrocortisone. The patient must have an emergency injection at home
Acute illness, trauma, surgery Parenteral hydrocortisone, at a dose according to the local protocol. Usually a bolus followed by repeated doses or an infusion
Suspected adrenal crisis Give the corticosteroid immediately. Do not wait for laboratory results. Take a serum cortisol and ACTH first only if this does not delay treatment. Plus fluid and glucose

Adrenal crisis: hypotension that does not respond to fluid, abdominal pain, vomiting, fever, hyponatraemia, hyperkalaemia, hypoglycaemia. Give hydrocortisone and an isotonic crystalloid. Exact doses according to the local protocol.

Tapering after pharmacological treatment

Duration and dose Risk of HPA suppression Tapering
< 3 weeks, at any dose Low Can be stopped straight away
> 3 weeks, prednisolone < 5 mg/day Low to moderate Can usually be stopped without a prolonged taper
> 3 weeks, prednisolone ≥ 5 mg/day Substantial A stepwise taper. More quickly down to the physiological level, then slowly
Months to years Marked A slow taper, often over months. Consider an ACTH test before stopping

During and after the taper the patient must be informed about the stress-dosing rules and about the symptoms of adrenal insufficiency.

Prophylaxis during longer corticosteroid treatment

Risk Action
Osteoporosis Calcium and vitamin D. A bisphosphonate with longer treatment and risk factors, according to the guideline
Hyperglycaemia Glucose measurement, above all in the afternoon and evening. See the quick reference on inpatient insulin therapy
Peptic ulcer A proton pump inhibitor with concomitant NSAID use or a history of ulcer, not routinely
Infection Consider Pneumocystis prophylaxis with high doses over a long period, according to the local protocol
Psychiatric symptoms Sleep disturbance, hypomania, confusion. Commonest early on and at high doses
Muscle weakness Steroid myopathy, with proximal weakness

Red flags and pitfalls

  • Stopping a corticosteroid abruptly after longer-term treatment.
  • Not giving a stress dose to a patient with adrenal insufficiency during acute illness.
  • Confusing dexamethasone 0.75 mg with prednisolone 0.75 mg. A tenfold difference in effect.
  • Giving the morning dose late in the day, which causes sleep disturbance and more marked HPA suppression.
  • Inhaled and topical steroids in high doses can also cause systemic suppression.
  • Corticosteroids mask fever and peritonitis. The abdomen of a patient on corticosteroids can be silent despite perforation.

Sources

  • Endocrine Society clinical practice guideline on the diagnosis and treatment of primary adrenal insufficiency.
  • The summary of product characteristics for each glucocorticoid preparation.
  • Internetmedicin, Adrenal insufficiency and Addisonian crisis.

Authors

EBM AI
Evidensbaserad AI-agent

Updated August 22, 2026